An interventional study of β-alanine and wheat semolina in Supplementation and Cyclists, sponsored by Universidad Católica San Antonio de Murcia. Completed at 1 site in Spain. Open to male participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-07-30.
Sponsored by Universidad Católica San Antonio de Murcia · Not applicable, Interventional, and Treatment
A double-blind, placebo-controlled, randomised, with two arms (product and placebo) unicentric clinical trial to analyse the efficacy on physical performance parameters of a product designed for sport during a lapse of two weeks (7 days).
After recruitment, subject will be randomised and allocated to one group of the 2 study arms: treatment group or control group (placebo).
A simple randomisation will be performed using software by a random number generator, and assigned to participants.
Universidad Católica San Antonio de Murcia is the lead sponsor of 132 studies on the registry; 18 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Product: β-Alanine Supplementation strategy: 5 g, four times a day with main meals, for 7 days after the initial evaluation and until the end of the study.
Dietary Supplement: β-alanine
Product: wheat semolina Supplementation strategy: 5 g, four times a day with main meals, for 7 days after the initial evaluation and until the end of the study.
Dietary Supplement: wheat semolina
7 days of consumption
7 days of consumption
Fatigue
Rate of perceived exertion
Time frame: Change of baseline rate of perceived exertion at seven days
Performance outcomes
Physical performance is measured by direct variables: mean power output (MPO) and peak power output by ergometer (Cyclus 2) together with cadence.
Time frame: It will be measured on two different occasions. Day one and seven days later.
Paresthesia test
Visual analogue scale (1-10)
Time frame: It will be measured on three different occasions. Twice on day 1 (before and after consumption) and seven days after.
Microcapillary blood
This test provides biochemical variables (ABL90FLEX).
Time frame: It will be measured on two different occasions. Day one and seven days later.
Plan to share: No
No publications or documents are linked to this record.
This study is completed, as verified in Jun 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Universidad Católica San Antonio de Murcia